SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

Bitcoin is trending due to significant volatility, with the community discussing its role as a potential safe haven amidst geopolitical tensions, alongside speculation about institutional movements and a potential short squeeze from high leveraged positions.

Bridgford Foods Corp. engages in the manufacture, market, and distribution of frozen and snack food products. It operates through the Frozen Food Products and Snack Food Products segments. The Frozen Food Products segment manufactures and distributes food products, including biscuits, bread dough items, roll dough items, and sandwiches. The Snack Food Products segment distributes both products manufactured by the company and third parties. The company was founded by Hugh H. Bridgford in February 1932 and is headquartered in Dallas, TX.

Bridgford Foods Corp.

Bridgford Foods Corporation

Bridgford Foods is trending after its latest earnings report significantly exceeded expectations, with the community highlighting the company's extremely low share float and aggressive push into private-label offerings with major retailers. Investors are also anticipating potential margin benefits from political initiatives aimed at lowering beef import prices, seeing the stock as an undervalued defensive play within the food sector.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is trending as geopolitical escalations, notably reported attacks on Iranian oil infrastructure and the ongoing disruption to the critical Strait of Hormuz, are fueling community speculation of a significant oil price surge, while other investors debate the sustainability of the rally amid potential market interventions.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Eli Lilly is strengthening its position as the leader in the GLP-1 market following news that Novo Nordisk's CagriSema did not meet the efficacy of Lilly's Tirzepatide in a recent trial, generating renewed bullish interest. The community is actively discussing the upcoming FDA approval of Lilly's oral weight-loss pill, orforglipron, and the positive implications from increased regulatory scrutiny on compounded GLP-1 alternatives.

PENGU is the official coin of Pudgy Penguins.  Pudgy Penguins has become the face of crypto with one of the most influential communities in the industry. From large companies wearing the Penguin, to being featured in ETF commercials, to garnering millions of followers and over 100 billion views, the Pengu has become a cultural icon making PENGU the world’s social currency.  PENGU allows for the ever-expanding Pudgy Penguin fanbase and the hundreds of millions of people outside of crypto that see and share the Pudgy Penguin everyday, to join The Huddle. PENGU is a symbol for community, memes, and good vibes.  Believe in Pengu. Believe in the Prophecy.

Pudgy Penguins

Pudgy Penguins (PENGU) is trending amid community excitement over its increasing mainstream brand visibility, including a high-profile presence on the Las Vegas Sphere and new collaborations with brands like NHL and Care Bears. This fuels discussions about its long-term potential and utility, differentiating it from other meme coins, despite ongoing price volatility.

Direxion Shares ETF Trust - Direxion Daily South Korea Bull 3X Shares

Direxion Daily South Korea Bull 3X Shares

KORU is trending amidst intense debate, driven by soaring HBM memory chip demand and positive price forecasts from major South Korean tech companies, while traders weigh the 3x leveraged ETF's extreme volatility against broader geopolitical headwinds.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

uniQure is trending as the departure of a high-ranking FDA official, previously critical of gene therapies, is widely seen by the community as a potential positive shift for the sector. This has reignited debate on whether QURE's Huntington's disease treatment will find a more favorable regulatory path or if the stock's recent volatility is primarily driven by a short squeeze.

Frontera Energy Corp. engages in the exploration, development, production, transportation, storage, and sale of oil and natural gas. It operates interests in exploration and production blocks in Colombia, Ecuador and Guyana, and pipeline and port facilities in Colombia. The company was founded on April 10, 1985 and is headquartered in Calgary, Canada.

Frontera Energy Corporation - Ordinary Shares New

Frontera Energy is trending amidst an escalating bidding war for its Colombian E&P assets, driven by a new premium acquisition proposal, which is fueling community discussion about the substantial, potentially undervalued, remaining infrastructure business and the future of its Guyana exploration block.

America's Oil Reserve for the Digital Age

U.S Oil

USOR CRYPTO is experiencing heightened attention driven by anticipation for a rumored "Feb 1st" event, sparking a polarized community debate between those expecting a massive pump and others warning it's a scam or "rug pull" memecoin with no actual connection to US oil.

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Amarin Corp - ADR

Amarin is trending as community discussion focuses on its strategic exclusion from China's national drug list, aiming to preserve pricing power, while investors keenly await a pending U.S. Supreme Court decision on its patent infringement case, which has broad implications for "skinny labels." This coincides with anticipated positive financial results and ongoing speculation about a potential acquisition, notably involving Novartis.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BioNTech (BNTX) Expected to Announce Quarterly Earnings on Monday

BioNTech (NASDAQ:BNTX) will be releasing its Q4 2025 earnings before the market opens on Monday, March 9. (View Earnings Report at...

Primecap Management Co. CA Sells 130,700 Shares of BioNTech SE Sponsored ADR $BNTX

Primecap Management Co. CA trimmed its holdings in shares of BioNTech SE Sponsored ADR (NASDAQ:BNTX - Free Report) by 3.3% during the 3rd quarter, according to its most recent disclosure with the...

Immuno-Oncology Investments Accelerate as Pipeline Catalysts Multiply in 2026

Immuno-Oncology Investments Accelerate as Pipeline Catalysts Multiply in 2026 Immuno-Oncology Investments Accelerate as Pipeline Catalysts Multiply in 2026 PR Newswire VANCOUVER, BC, Feb. 25, 2026...

BioNTech SE Sponsored ADR (NASDAQ:BNTX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Shares of BioNTech SE Sponsored ADR (NASDAQ:BNTX - Get Free Report) have received an average rating of "Moderate Buy" from the sixteen research firms that are presently covering the company...

BioNTech SE Sponsored ADR $BNTX Shares Sold by CenterBook Partners LP

CenterBook Partners LP trimmed its position in shares of BioNTech SE Sponsored ADR (NASDAQ:BNTX - Free Report) by 14.1% during the third quarter, according to the company in its most recent Form 13F...

Aberdeen Group plc Has $28.79 Million Stock Position in BioNTech SE Sponsored ADR $BNTX

Aberdeen Group plc lowered its stake in BioNTech SE Sponsored ADR (NASDAQ:BNTX - Free Report) by 59.6% during the third quarter, according to the company in its most recent Form 13F filing with the...

BMY Up 7.6% Post Q4 Earnings: Should You Buy, Sell or Hold the Stock?

BMY jumps after strong Q4 2025 results as its growth portfolio drives beats, lifts sentiment and offsets generic pressure on legacy drugs.

Pfizer Stock Slides Despite Q4 Earnings Beat and New Obesity Drug Data

PFE shares fall even after Q4 earnings beat on COVID product declines and muted investor reaction to new obesity drug data.

Should You Buy, Hold, or Sell BMY Stock Ahead of Q4 Earnings?

BMY heads into Q4 2025 earnings with strong Opdivo momentum, even as generic pressure continues to weigh on legacy drug sales.

Lingohr Asset Management GmbH Acquires 40,821 Shares of BioNTech SE Sponsored ADR $BNTX

Lingohr Asset Management GmbH boosted its position in shares of BioNTech SE Sponsored ADR (NASDAQ:BNTX - Free Report) by 598.4% during the 3rd quarter, according to its most recent 13F filing with...

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

Current Price	$101.50
Prev Close	$101.95
Open	$99.00
Dividend Yield	0.00%
50-Day Moving Average	$106.29
Beta	0.84
Avg. Volume	617,511.21
PE Ratio	-38.60

52-Week High	$124.00
52-Week Low	$81.20
Market Capitalization	$24.41B
EPS (Annual)	-$2.99
Price to Book	1.12
Revenue Per Employee	$439,432.88

BNTX
BioNTech SE - ADR

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BNTX News

BNTXBioNTech SE - ADR